[Cost-effectiveness advantage? Pharmacoeconomic aspects of biosimilars].
IPF Institut für Pharmaökonomische Forschung, Wolfengasse 4/7, 1010 Wien. e.walter@ipf-ac.at
Evelyn
E
Walter
D059451:Biosimilar Pharmaceuticals / Q000191:economics*; D003363:Cost Control; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D005060:Europe; D006801:Humans
D059451:Biosimilar Pharmaceuticals